359 related articles for article (PubMed ID: 17187404)
1. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.
Visvanathan K; Skinner NA; Thompson AJ; Riordan SM; Sozzi V; Edwards R; Rodgers S; Kurtovic J; Chang J; Lewin S; Desmond P; Locarnini S
Hepatology; 2007 Jan; 45(1):102-10. PubMed ID: 17187404
[TBL] [Abstract][Full Text] [Related]
2. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.
Chen Z; Cheng Y; Xu Y; Liao J; Zhang X; Hu Y; Zhang Q; Wang J; Zhang Z; Shen F; Yuan Z
Clin Immunol; 2008 Sep; 128(3):400-8. PubMed ID: 18565796
[TBL] [Abstract][Full Text] [Related]
3. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
Visvanathan K; Lang T; Ryan K; Wilson R; Skinner NA; Thompson AJ; Ahn SH; Weilert F; Abbott W; Gane E; Colledge D; Li K; Locarnini S; Mansell A; Revill PA
J Viral Hepat; 2016 Mar; 23(3):170-9. PubMed ID: 26436722
[TBL] [Abstract][Full Text] [Related]
4. [The influence of hepatitis B e antigen on the expression of toll-like receptor 2 on peripheral monocytes].
Han YP; Li J; Wan YF; Kong LH; Cai J; Dong L; Liu Y; Chen N; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2008 Oct; 16(10):739-42. PubMed ID: 18983769
[TBL] [Abstract][Full Text] [Related]
5. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg].
Li YW; Yang HZ; Ke QS; Chen W; Chen XJ
Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
[TBL] [Abstract][Full Text] [Related]
7. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
Kim HJ; Yoo BC
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
[TBL] [Abstract][Full Text] [Related]
8. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
[TBL] [Abstract][Full Text] [Related]
9. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
Chauhan R; Kazim SN; Bhattacharjee J; Sakhuja P; Sarin SK
J Med Virol; 2006 Aug; 78(8):1047-54. PubMed ID: 16789012
[TBL] [Abstract][Full Text] [Related]
10. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan.
Wu JF; Chen CH; Ni YH; Lin YT; Chen HL; Hsu HY; Chang MH
J Infect Dis; 2012 Sep; 206(5):662-8. PubMed ID: 22740716
[TBL] [Abstract][Full Text] [Related]
12. [Expressions and significance of TLR2 and TLR4 in Kupffer cells of tree shrews chronically infected with hepatitis B virus].
Ruan P; Yang C; Su J; Ou C; Cao J; Luo C; Tang Y; Qin H; Sun W; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):686-90. PubMed ID: 25001929
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
Rodriguez-Frias F; Jardi R; Buti M; Schaper M; Hermosilla E; Valdes A; Allende H; Martell M; Esteban R; Guardia J
J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B.
Riordan SM; Skinner N; Kurtovic J; Locarnini S; Visvanathan K
Clin Vaccine Immunol; 2006 Aug; 13(8):972-4. PubMed ID: 16894001
[TBL] [Abstract][Full Text] [Related]
16. Regulation of B7-H1 expression on peripheral monocytes and IFN-γ secretion in T lymphocytes by HBeAg.
Han Y; Li J; Jiang L; Xu Q; Liu B; Jin K; Liu Y; Huang Z
Cell Immunol; 2013; 283(1-2):25-30. PubMed ID: 23850673
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]